Eosinophilic otitis media as a disease associated with chronic nasal polyposis and bronchial asthma

Close metadata

Recommended articles:

Immunotherapy in the treatment of chronic polypous rhinosinusitis with comorbid bronchial asthma. Russian Bulletin of Otorhinolaryngology. 2025;(1):29-34

Esophageal pathology and bronchial asthma: pathogenetic interactions and possibilities for therapy optimization. Russian Journal of Preventive Medicine. 2024;(11):129-134

Chronic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medicine. 2025;(1):115-121

Accessibility of health and preventive care for patients with bronchial asthma. Journal of Respiratory Medicine. 2025;(1):15-22

Efficacy of dupilumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):204-209

Neutrophil elastase as a promising biomarker of low-grade inflammation in chronic non-communicable diseases. Russian Journal of Preventive Medicine. 2025;(4):142-148

Rather few publications devoted to eosinophilic otitis media (EoOM) can be found in the literature. This condition refractory to the treatment is characterized by the elevated number of eosinophils in the exudate and mucosal membrane of the middle ear. The disease is not infrequently associated with bronchial asthma and polypous rhinosinusitis. The patients presenting with eosinophilic otitis media suffer the progressive loss of hearing; some of them all of a sudden develop deafness. The present literature reviews is focused on the clinical features of eosinophilic otitis media and the available methods for its treatment.

Keywords:

eosinophilic otitis media

bronchial asthma

chronic polypous rhinosinusitis

Authors:

Kosiakov S.Ia.

Kafedra otorinolaringologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Gunenkov A.V.

Kafedra otorinolaringologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

List of references:

Iino Y., Tomioka-Matsutani S., Matsubara A., Nakagawa T., Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx 2011; 38: 456-461.
Tomioka S., Kobayashi T., Takasaka T. Intractable otitis media in patients with bronchial asthma. In: M. Sanna ed. Cholesteaioma and Mastoid Surgery. Rome, Italy: Edizioni Internazionali 1997; 851-853.
Iino Y., Nagamine H., Yabe T. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 2001; 31: 1135-1143.
Nagamine H., Iino Y., Kojiroa C. Clinical characteristics of so-called eosinophilic otltis media. Auris Nasus Larynx 2002; 29: 19-28.
Settipane G.A. Epidemiology of nasal polyps. Allergy Asthma Proc 1996; 17: 231-236.
Iino Y., Kakizaki K., Saruya S. Eustachian Tube Function in Patients With Eosinophilic Otitis Media Associated With Bronchial Asthma Evaluated by Sonotubometry. Arch Otorhinolaryngol Head Neck Surg 2006; 132: 1109-1114.
Virtanen H. Sonotubometry: an acoustical method for objective measurement of auditory tubal opening. Acta Otolaryngol 1978; 86: 93-103.
Reiss M., Reiss G. Patulous eustachian tube - diagnosis and therapy [in German; abstract in English]. Wien Med Wochenschrift 2000; 150: 454-456.
Tsuji T., Yamaguchi N., Moriyama H. Patulous eustachian tube following otitis media. Nippon Jibiinkoka Gakkai Kaiho 2003; 106: 1023-1029.
Virtanen H., Palva T. The patuious eustachian tube and chronic middle ear disease. Acta Otolaryngol 1982; 93: 49-53.
Takashi N., Matsubara A., Shiratsuchi H. Intractable Otitis Media with Eosinophils: Importance of Diagnosis and Validity of Treatment for Hearing Preservation. ORL 2006; 68: 2: 118-122.
Yino Y., Kakizaki K., Katano H. Eosinophil chemoattractant in middle ear of patients with eosinophilic otitis media. Clin Exp Allergy 2005; 35: 1370-1376.
Mori A., Kaminuma O., Suko M. Cellular and moleculai mechanisms of IL-5 synthesis in atopic diseases: a study with allergen-specific human helper T cells. Allergy Clin Immunol 1997; 100: 56-64.
Medhekar S. Leukocytoclastic vasculitis: a window to systemic CHURG STRAuss Syndrome. Indian J Dermatol 2012; 57: 3: 215-218.
Ponikau J.U., Sherris D.A., Oern E.B. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877-884.
Katzenstein A.L., Sale S.R., Greenberger P.A. Allergic Aspergilus sinusitis: a newly recognized form of sinusitis. Allergy Clln Immunol 1983; 72: 89-93.
Ferguson B.J. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000; 110: 799-813.
Iino Y., Nagamine H., Yabe T. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma. Clin Exp Allergy 2001; 31: 1135-1143.
Derlack E.L. Aural manifestations of allergy. Ann Otorhinolaryngol 1952; 1: 179-188.
Chung J. Eosinophilic Otitis Media: CT and MRI Findings and Literature Review. Korean J Radiol 2012; 13: 3: 363-367.
Takashi N., Matsubara A., Shiratsuchi H. intractable otitis media with eosinophils: importance of diagnosis and validity of treatment for hearing preservation. ORL 2006; 68: 118-122.
Iino Y. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma. Otol Neurotol 2008; 29: 7: 949-952.
Iino Y., Kakizaki K., Katano H. Eosinophil chemoattractant in middle ear of patients with aosinophilic otitis media. Clin Exp Allergy 2005; 35: 10: 1370-1376.
Iino Y., Nagamine H. Effectiveness of instillation of triamcenolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol 2006; 97: 6: 761-766.
Rodrigo G.J., Neffen H., Castro-Rodriguez J.A. Efficacy and safety of subcutaneous omalizunab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest 2011; 139: 28-35.
Yoshido N. Patulous eustachian tube develops the eosinophilic otitis media followed by chronic rhinosinusitis. Proc the 9th international Conference on cholesteatoma and ear surgery. Nagasaki, Japan 2012; 163.
Iino Y., Hara M., Hasegawa M., Matsuzawa S. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media. Otology & Neurotology 2012; 33: 7: 1218-1223.
Wada T., Uemaetomari H., Tobita T. Successful treatment of Eosinophilic otitis media using ramatroban: report of two cases. Auris Nasus Larynx 2006; 33: 4: 455-460.
Shambaugh G.E. Surgery of the ear, 2nd ed. WB Saunders Co, Philadelphia 1967; 210-211, 222, 255-256, 272.
Tomioka S., Yuasa R., Iino Y. Intractable otitis media in cases with bronchial asthma. In: G. Mogi, I. Honjo, T. Ishii, T. Takasaka. Recent advances in otitis media. Proceedings of the Second Extraordinary International Symposium. Kugler. Amsterdam-New York 1993; 183-186.
Iwasaki S., Nagura M., Mizuta K. Cochlear implantation in a patient with eosinophilic otitis media. Eur Arch Otorhinolaryngol 2006; 263: 365-369.
Seung-Ha Oh. Bilateral sudden hearing loss in eosinophilic otitis media patient: A case of cochlear implantation. Proc the 9th international Conference on cholesteatoma and ear surgery. Nagasaki, Japan 2012; 162.

Close metadata